Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
about
Adenosine receptors as therapeutic targetsThe A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channelAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.Recent developments in adenosine receptor ligands and their potential as novel drugsStructure-affinity relationships of adenosine A2B receptor ligandsUse of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cellsAdenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NOTargeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.Quinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors.Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation.New insights into the regulation of inflammation by adenosine.Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptorAdenosine and ischemic preconditioning.Purinergic receptors in gastrointestinal inflammation.IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptorsMast cells in a murine lung ischemia-reperfusion model of primary graft dysfunctionThe role of activated adenosine receptors in degranulation of human LAD2 mast cells.Xanthines as adenosine receptor antagonists.Progress in the pursuit of therapeutic adenosine receptor antagonists.International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateAdenosine receptor subtype-selective antagonists in inflammation and hyperalgesia.Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cellsSynthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition processHuman breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal.Adenosine A3 receptors: novel ligands and paradoxical effects.A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophilsAcute adenosinergic cardioprotection in ischemic-reperfused hearts.Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A₃ adenosine receptor.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsActivation of adenosine₁ receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in ratsStructure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor.Disparity in FcεRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine.Enhanced mast cell activation in mice deficient in the A2b adenosine receptor.A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammationSynthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubility.The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems.
P2860
Q24632095-4C9D57DF-1E8E-49BE-B6F8-4FE0222CA8C5Q24651378-CA87FEE4-AF48-4694-A2D3-6FB8C37611D3Q24651475-BAFB353A-5281-423B-95E0-6C2B33576C07Q27687253-7509F9E3-50D6-40E1-A6BE-0947A1A762FFQ28252689-EE001F68-3989-4E55-9529-97C9D12E984AQ28343854-6B4AFF1C-25DA-4018-8B7D-E69CBAA03DB2Q28346743-F149A450-8898-4D79-A244-802C45F2EBB2Q28362050-B3D385BC-6EA1-464D-B01B-F63DC276179DQ30307910-0A2E9C19-88D4-48F5-A7B8-6BDF03109261Q30424843-0914C21C-0620-48AC-8D64-EAB96961C1FFQ30435373-519EFED3-F826-43BF-9EC4-131E5A76796CQ30438024-53ADAF67-2B02-42E0-9203-D0307336F93DQ30440914-20ABB9CD-6321-4C3A-8891-5734745DFE4CQ30453517-D9C3EA45-5632-48B3-8C7A-38B513BA131BQ33399655-0CADBE31-4FD5-4183-8D1B-F8F0708A1C19Q33516043-1354B85C-9BCD-4B77-ACA3-EFF27EA1158DQ33801903-AE68896C-4BAB-45C2-B589-D3DAAAB919A8Q34008598-66181167-E1FF-4625-9B6F-3BBA4262DC85Q34037868-C0C9491E-3B37-4575-8CE3-80BC5D4CF7B3Q34117423-9C882744-BDF3-44F6-8578-81C31B62140DQ34123216-6592F4F6-EA77-4E53-A9AA-676A7BF37021Q34139398-DEA91606-88EC-4BF7-B178-914B8FC0B86FQ34480029-309B2321-EDC2-4178-BAA7-6D19337EE47EQ34701303-A8595865-F3D9-4061-BADE-388A24AA94E5Q34734932-06E108F5-2040-4A89-9CDD-5F44A99DBE63Q34779773-324B91FA-413E-4D4B-9811-7C7E667DE759Q35020369-919830B7-4B43-4F61-AE64-E9060457A049Q35048860-B27DEFBE-6B5F-488F-8150-480182CE7214Q35171034-C5755C80-165E-49C9-AE7A-46240405E9AFQ35188154-A5F1D32D-8958-4F97-AE9A-A567D7672E05Q35560907-F8B20BE5-8C44-4146-9A63-6A4B7C59E3FDQ35650779-42F4BE6E-E278-4DAA-82F4-0A9E45B01509Q35788500-45F1673E-9F67-44A1-AF23-92E79C928E8DQ35913141-438C82BC-3F73-44F9-9923-95F072D7DB1FQ36116925-1E28C9A1-FB72-40D4-86E3-7F05923ECFF2Q36158473-C78EF498-B848-4305-96CD-99958F691CB5Q36228909-A226EB7E-0113-447D-8261-C0AC85C64EC7Q36252460-225D6ED4-0450-4133-BA86-FCA261098C5BQ36626953-B309B87D-5450-42CE-BCAE-68FE4B97A5E3Q36654416-D7FC0368-6207-46A7-BA21-706658CA1FCE
P2860
Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@ast
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@en
type
label
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@ast
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@en
prefLabel
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@ast
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@en
P2093
P356
P1476
Canine mast cell adenosine rec ...... mediated by the A2B receptor.
@en
P2093
P304
P356
10.1124/MOL.52.5.846
P577
1997-11-01T00:00:00Z